cdy annc:
Sydney, 4 March 2010: Cellmid (ASX:CDY) today signed research, development and collaboration agreements with Pharmahungary for the pre-clinical and early clinical validation programs for midkine to treat heart attack (acute myocardial infarction or AMI).
Well that's a relieve if u bought at high
n feel some acute myocardial infarction
Here's a better release:
KayaRaya inc annc validation programs for
heart attack prevention:
*5 veg n 2 fruits
*Exercise
*DYOR
LOL
K R
No Pain No Gain bumper sticker issuer.
- Forums
- ASX - Day Trading
- daytrades march 3 morning ...
daytrades march 3 morning ..., page-11
-
- There are more pages in this discussion • 161 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online